PUBLICATIONS · 15494430
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2005 Feb 15
- First author
- Marcus R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Marcus R
- type
- Author
- name
- Imrie K
- type
- Author
- name
- Belch A
- type
- Author
- name
- Cunningham D
- type
- Author
- name
- Flores E
- type
- Author
- name
- Catalano J
- type
- Author
- name
- Solal-Celigny P
- type
- Author
- name
- Offner F
- type
- Author
- name
- Walewski J
- type
- Author
- name
- Raposo J
- type
- Author
- name
- Jack A
- type
- Author
- name
- Smith P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Marcus R
- type
- Author
- name
- Imrie K
- type
- Author
- name
- Belch A
- type
- Author
- name
- Cunningham D
- type
- Author
- name
- Flores E
- type
- Author
- name
- Catalano J
- type
- Author
- name
- Solal-Celigny P
- type
- Author
- name
- Offner F
- type
- Author
- name
- Walewski J
- type
- Author
- name
- Raposo J
- type
- Author
- name
- Jack A
- type
- Author
- name
- Smith P
- type
- Author
- bibliography ids
- nci-bib-a8b4faa0a45f3ad2fa9a6155
- book metadata
- content sha256
- 2e8e5843c1e2a9049a5000b090da491456a151a5f9cb37632af1c6da481ec0ba
- document type
- citation
- dois
- 10.1182/blood-2004-08-3175
- electronic publication date
- display
- 2004 Oct 19
- precision
- day
- year
- 2004
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15494430
- immutable id
- pubmed:15494430@2e8e5843c1e2a9049a5000b090da491456a151a5f9cb37632af1c6da481ec0ba
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 4
- name
- Blood
- nlm unique id
- 7603509
- pages
- 1417-23
- volume
- 105
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15494430
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- f3386b2ecd227dfc28a2cc7102998ccc48ddcdd7b3bb443e790721b91ac2066f
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2005 Feb 15
- precision
- day
- year
- 2005
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle